Pennsylvania · Ranked 259 of 1033 by CEO pay.
The American Oncologic Hospital
Robert Uzzo, President & CEO. Fiscal year ending 2025-06.
Form 990 Part VII, columns D+E+F
Schedule H Part I line 7a
Most of the reported compensation ($1,509,681 of $1,582,504) came from a related organization (Part VII column E) and was reported on this filing.
§1The filing
- Total revenue
- $411,324,903
- Total expenses
- $326,196,462
- Net assets
- $179,873,853
- Employees
- 1,673
- Hospitals covered
- 3 facilities across 1 filing
- Charity care, net
- $388,000
- Bad debt
- Medicare surplus (shortfall), as filed
- ($6,493,000)
- CEO pay from the organization (Part VII col. D)
- $0
- From related organizations (col. E)
- $1,509,681
- Other compensation, including deferred pay and nontaxable benefits (col. F)
- $72,823
- CEO total compensation (D+E+F)
- $1,582,504 to Robert Uzzo
Medicare surplus (shortfall) is Schedule H Part III line 7: Medicare revenue minus the cost of Medicare care. A figure in parentheses is a shortfall. Like bad debt, it is not community benefit on the IRS form.
Source: Form 990, The American Oncologic Hospital, EIN 23-1352156, fiscal year ending 2025-06, as published by the IRS. CEO identification: ceo title.
§2Community benefit versus charity care
The rest of line 7k is Medicaid shortfall, medical education, research, subsidized services and contributions. Bad debt () and Medicare shortfall are reported separately by the IRS and are not community benefit on the form.
Every number on this page was copied from the filing linked above. If a figure is wrong, send the filing that contradicts it and the correction runs at the top of this page.
§Share
